The International Lung Cancer Consortium (ILCCO)

The International Lung Cancer Consortium (ILCCO) was founded in 2004 by a group of lung cancer researchers from around the world with the aim of compiling comparable data from ongoing epidemiological studies of the lung.

The aim is to increase statistical power, especially in subgroup analyses, avoid the duplication of research efforts, replicate new results, and achieve substantial cost savings through collaborative projects.

The consortium coordinates the genotyping of individual genetic variants and conducts collaborative genome-wide studies. Questionnaire data from tens of thousands of case-control pairs in participating case-control studies from different countries and ethnic populations as well as biomaterial from the majority of all study participants are available to all consortium members.

The Department participates with data from the German Lung Cancer Study and is involved in numerous collaborative projects. Heike Bickeböller has once again been working as a member of the steering committee since 2021.

ILCCO Coordinator
Dr. Rayjean J. Hung

Page last updated March 2023